Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Stoke Therapeutics, Inc. | Former CFO | Restricted Stock Units | 40K | $631K | $15.78 | Mar 27, 2024 | Direct |
Stoke Therapeutics, Inc. | Former CFO | Common Stock | 20.7K | $127K | $6.10 | Mar 19, 2024 | Direct |
Stoke Therapeutics, Inc. | Former CFO | Employee Stock Option (Right to Buy) | 60K | Mar 27, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
STOK | Stoke Therapeutics, Inc. | Mar 27, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Former CFO |
STOK | Stoke Therapeutics, Inc. | Mar 15, 2024 | 3 | -$25.1K | 4 | Mar 19, 2024 | CFO |
STOK | Stoke Therapeutics, Inc. | Dec 1, 2023 | 4 | $0 | 4 | Dec 5, 2023 | CFO |
STOK | Stoke Therapeutics, Inc. | Mar 15, 2023 | 2 | $0 | 4 | Mar 17, 2023 | CFO |
STOK | Stoke Therapeutics, Inc. | Dec 7, 2022 | 1 | $0 | 4 | Dec 9, 2022 | CFO |
STOK | Stoke Therapeutics, Inc. | Jun 2, 2022 | 2 | $50K | 4 | Jun 3, 2022 | CFO |
STOK | Stoke Therapeutics, Inc. | Mar 15, 2022 | 1 | $0 | 4 | Mar 17, 2022 | CFO |